Longevity
Chonluten
Immunity
3
Amino acids
Molecular weight
Peptide
Type
Chonluten is a Khavinson bioregulator tripeptide (EDG) derived from respiratory lung tissue. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology, it targets the bronchopulmonary system with secondary activity in the GI tract. Research shows it regulates genes related to inflammation, antioxidant activity, and proliferation responses. Chonluten inhibits TNF production in monocytes and has been studied as a potential geroprotective agent that may support lung function in conditions like COPD.
Chonluten works through epigenetic regulation, penetrating cell and nuclear membranes to bind promoter or suppressor regions of DNA and modulate transcriptional control. It regulates genes including c-Fos, HSP70 (heat-shock protein), SOD (superoxide dismutase), COX-2, and TNF-alpha related to oxidative stress and proliferative regulation. The peptide inhibits TNF production in monocytes exposed to pro-inflammatory LPS, promoting attenuation of inflammatory action through TNF tolerance mechanisms.
Capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated
Once daily for 10-20 consecutive days
10-20 mg daily
10-20 days per cycle
Normalizes respiratory system function
Regulates protein synthesis in lung tissue
Inhibits inflammatory TNF production
Restores lung alveolar tissues
Maintains bronchial mucous membranes
Supports antioxidant gene expression
May slow cell aging (geroprotective)
Modulates mucosal function
This peptide is still gaining traction in the community.
EDG Tripeptide | Bronchial/Lung Bioregulator
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of Chonluten.
3
Amino Acids
Chonluten
Glu
Glu
Position 1
Asp
Asp
Position 2
Gly
Gly
Position 3
Available in capsule form for oral administration. As a tripeptide, Chonluten has favorable permeability across cellular compartments. Typical protocol involves 10-20 day cycles.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10 | 10 week range | Oral capsules |
| Maintenance | 10 | 2 week range | Oral capsules |
The Chonluten Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
Chonluten
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Chonluten vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of Chonluten interactions with other common peptides and substances.
Healing
bpc
Longevity
COMPATIBLE
Both support mucosal health through different mechanisms.
Immunity
bro
SYNERGISTIC
Related respiratory bioregulators; complementary mechanisms.
Longevity
cry
Immunity
COMPATIBLE
Both have immune-modulating properties; different tissue targets.
Longevity
epi
Immunity
SYNERGISTIC
Often combined in comprehensive anti-aging Khavinson protocols.
Active respiratory emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Allergic reactions
Unusual respiratory symptoms
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Chonluten is a moderate research compound
Chonluten
Chonluten is a moderate research compound
Peptides Regulating Proliferative Activity and Inflammatory Pathways in THP-1 Cells
Chonluten tripeptide inhibits TNF production in monocytes exposed to pro-inflammatory LPS.
n.d.
Chonluten and Gene Expression Regulation
Chonluten regulates c-Fos, HSP70, SOD, COX-2, and TNF-alpha gene expression.
n.d.
Bronchial Bioregulator Peptides
Short peptides derived from bronchial tissue regulate protein synthesis in lung cells.
n.d.
Khavinson Peptide Bioregulators
Comprehensive review of bioregulator peptides including Chonluten and their mechanisms.
n.d.